lasonolide A

structure in first source

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 01/08/2014 - "Lasonolide A is a novel polyketide displaying potent anticancer activity across a broad range of cancer cell lines. " 12/01/2012 - "Lasonolide A (LSA) is a natural product with high and selective cytotoxicity against mesenchymal cancer cells, including leukemia, melanomas and glioblastomas. " 01/01/2020 - "We used insertional mutagenesis-based screens in haploid cells to identify genes required for the sensitivity to lasonolide A (LasA), a macrolide derived from a marine sponge that kills certain types of cancer cells at low nanomolar concentrations. "
2.	Pancreatic Neoplasms (Pancreatic Cancer) 11/01/2009 - "Contrary to expected results, we found lasonolide A to be a strong activator of PKC in Panc-1 pancreatic carcinoma cells. " 11/01/2009 - "Early effects of lasonolide a on pancreatic cancer cells."
3.	Melanoma (Melanoma, Malignant) 12/01/2012 - "Lasonolide A (LSA) is a natural product with high and selective cytotoxicity against mesenchymal cancer cells, including leukemia, melanomas and glioblastomas. "
4.	Leukemia 12/01/2012 - "Lasonolide A (LSA) is a natural product with high and selective cytotoxicity against mesenchymal cancer cells, including leukemia, melanomas and glioblastomas. "
5.	Glioblastoma (Glioblastoma Multiforme) 12/01/2012 - "Lasonolide A (LSA) is a natural product with high and selective cytotoxicity against mesenchymal cancer cells, including leukemia, melanomas and glioblastomas. "

1.	Polyketides
2.	Macrolides
3.	lipid-associated sialic acid (LASA)